Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/SB-431542> ?p ?o }
Showing triples 1 to 61 of
61
with 100 triples per page.
- SB-431542 abstract "SB-431542 is a drug candidate developed by GlaxoSmithKline (GSK) as an inhibitor of the activin receptor-like kinase (ALK) receptors, ALK5, ALK4 and ALK7. (It is NOT an ALK inhibitor).".
- SB-431542 thumbnail SB431542.png?width=300.
- SB-431542 wikiPageID "31942266".
- SB-431542 wikiPageLength "2905".
- SB-431542 wikiPageOutDegree "15".
- SB-431542 wikiPageRevisionID "703435985".
- SB-431542 wikiPageWikiLink ACVR1B.
- SB-431542 wikiPageWikiLink ACVR1C.
- SB-431542 wikiPageWikiLink ACVRL1.
- SB-431542 wikiPageWikiLink ALK_inhibitor.
- SB-431542 wikiPageWikiLink Category:Amides.
- SB-431542 wikiPageWikiLink Category:Benzodioxoles.
- SB-431542 wikiPageWikiLink Category:Imidazoles.
- SB-431542 wikiPageWikiLink Category:Protein_kinase_inhibitors.
- SB-431542 wikiPageWikiLink Enzyme_inhibitor.
- SB-431542 wikiPageWikiLink GlaxoSmithKline.
- SB-431542 wikiPageWikiLink Induced_pluripotent_stem_cell.
- SB-431542 wikiPageWikiLink Mesenchymal_stem_cell.
- SB-431542 wikiPageWikiLink Receptor_(biochemistry).
- SB-431542 wikiPageWikiLink TGF_beta_receptor_1.
- SB-431542 wikiPageWikiLink Transforming_growth_factor_beta.
- SB-431542 wikiPageWikiLinkText "SB-431542".
- SB-431542 imagefile "SB431542.png".
- SB-431542 wikiPageUsesTemplate Template:As_of.
- SB-431542 wikiPageUsesTemplate Template:Chembox.
- SB-431542 wikiPageUsesTemplate Template:Chembox_Hazards.
- SB-431542 wikiPageUsesTemplate Template:Chembox_Identifiers.
- SB-431542 wikiPageUsesTemplate Template:Chembox_Properties.
- SB-431542 wikiPageUsesTemplate Template:Ebicite.
- SB-431542 wikiPageUsesTemplate Template:Reflist.
- SB-431542 subject Category:Amides.
- SB-431542 subject Category:Benzodioxoles.
- SB-431542 subject Category:Imidazoles.
- SB-431542 subject Category:Protein_kinase_inhibitors.
- SB-431542 hypernym Candidate.
- SB-431542 type ChemicalCompound.
- SB-431542 type ChemicalSubstance.
- SB-431542 type Group.
- SB-431542 type Person.
- SB-431542 type Acetal.
- SB-431542 type Amide.
- SB-431542 type Chemical.
- SB-431542 type Diazole.
- SB-431542 type Ether.
- SB-431542 type Group.
- SB-431542 type Heterocycle.
- SB-431542 type Inhibitor.
- SB-431542 type ChemicalObject.
- SB-431542 type Thing.
- SB-431542 type Q11173.
- SB-431542 comment "SB-431542 is a drug candidate developed by GlaxoSmithKline (GSK) as an inhibitor of the activin receptor-like kinase (ALK) receptors, ALK5, ALK4 and ALK7. (It is NOT an ALK inhibitor).".
- SB-431542 label "SB-431542".
- SB-431542 sameAs Q7388913.
- SB-431542 sameAs اسبی-۴۳۱۵۴۲.
- SB-431542 sameAs m.0gvtcpz.
- SB-431542 sameAs SB-431542.
- SB-431542 sameAs SB-431542.
- SB-431542 sameAs Q7388913.
- SB-431542 wasDerivedFrom SB-431542?oldid=703435985.
- SB-431542 depiction SB431542.png.
- SB-431542 isPrimaryTopicOf SB-431542.